Cynthia Bamdad
, Chief Executive Officer and Chief Scientific Officer, Minerva Biotechnologies
Dr. Bamdad oversees all corporate strategy, and scientific and business operations of Minerva Biotechnologies. She was a pioneer in the field of biochips and is now recognized as a leader in the field of cancer stem cells and cancer immunotherapy. Dr. Bamdad holds a B.S. in Physics from Northeastern University and a Ph.D. in Biophysics from Harvard University, where she was a Howard Hughes Doctoral Fellow. While a Ph.D. student at Harvard, Dr. Bamdad invented the first electronic DNA chip and the first universal protein chip.
Dr. Bamdad has been the Principal Investigator on grants and contracts from the National Cancer Institute, National Institute for Mental Health, National Science Foundation, The Huntington Foundation, National Institute of General Medicine, the Defense Advanced Research Projects Agency (DARPA), and the Advanced Technology Program (ATP). She has served on special committees to advise research arms of the military on the technical challenges of detecting biological warfare agents (BWA). Dr. Bamdad has also given numerous invited talks to U.S. and foreign institutions on the topics of cancer, neurodegenerative diseases, and biological warfare threat and detection.
